Article

jdsupra.com on 2018-06-13 17:47

Blog: FDA Finalizes Two Guidance Documents Regarding Medical Product Communications

The U.S. Food and Drug Administration (FDA) released two final guidances yesterday regarding medical communications: Drug and Device Manufacturer ...

Related news

FDA Finalizes Guidance on Payor Communications jdsupra.com
California , United States , Switzerland
FDA Issues Final Guidance Documents Relating to Medical Product Manufacturer Communications jdsupra.com
California , United States , Switzerland
FDA Finalizes New Definition of Biological Product jdsupra.com
California , United States , Switzerland
FDA Finalizes Nutrition Labeling Guidance Documents jdsupra.com
California , United States , Switzerland
FDA Issues Guidance on Drug and Device Manufacturer Communications: Part II – Medical Product Communications that are Consistent with the FDA-Required Labeling jdsupra.com
California , United States , Switzerland
Guidances galore: FDA finalizes multiple digital health guidance documents jdsupra.com
California , United States , Switzerland
FDA and Life Sciences FDA Finalizes Guidances for “Consistent Communications” and Payor Communications jdsupra.com
California , United States , Switzerland
Medical Device Developments: FDA Finalizes Four 510(k) Guidance Documents jdsupra.com
California , United States , Switzerland
FDA Finalizes Guidance on Special 510(k) Pathway jdsupra.com
California , United States , Switzerland
FDA Releases Draft Guidance regarding the Low Calorie Sweetener – Allulose jdsupra.com
California , United States , Switzerland
FDA Issues Another Draft Guidance Regarding Biosimilar Interchangeability jdsupra.com
California , United States , Switzerland
FDA finalizes two guidances clarifying DSCSA enforcement exemptions and issues product identifier Q&A jdsupra.com
California , United States , Switzerland
FDA guidances promote greater communication to payors about medical product value, clarify CFL communications jdsupra.com
California , United States , Switzerland
FDA Withdraws Draft Guidance Regarding Statistical Approaches to Evaluate Analytical Similarity of Biosimilars jdsupra.com
California , United States , Switzerland
[Video] Life Sciences Quarterly (Q3 2019): SEC Enforcement and Class Actions Regarding FDA Communications jdsupra.com
California , United States , Switzerland
FDA Issues Draft Guidance On Biosimilar Licensure For Fewer Than All Conditions Licensed for Reference Product jdsupra.com
California , United States , Switzerland
Pfizer Submits Citizen Petition to FDA Regarding Communications About Biosimilars jdsupra.com
United States
FINRA Issues New Guidance Regarding Customer Communications Relating to Departing Registered Representatives jdsupra.com
California , United States , Switzerland
FDA finalizes 3D printing guidance jdsupra.com
FDA Issues Three Key Documents Relating to Medical Product Manufacturer Communications jdsupra.com
United States , Washington , Cures